Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1995 1
1996 6
1997 6
1998 9
1999 10
2000 6
2001 6
2002 16
2003 11
2004 18
2005 21
2006 17
2007 21
2008 23
2009 29
2010 32
2011 37
2012 26
2013 37
2014 48
2015 39
2016 32
2017 28
2018 22
2019 17
2020 24
2021 32
2022 18
2023 9
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

528 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Tamsulosin on Passage of Symptomatic Ureteral Stones: A Randomized Clinical Trial.
Meltzer AC, Burrows PK, Wolfson AB, Hollander JE, Kurz M, Kirkali Z, Kusek JW, Mufarrij P, Jackman SV, Brown J. Meltzer AC, et al. JAMA Intern Med. 2018 Aug 1;178(8):1051-1057. doi: 10.1001/jamainternmed.2018.2259. JAMA Intern Med. 2018. PMID: 29913020 Free PMC article. Clinical Trial.
IMPORTANCE: Urinary stone disease is a common presentation in the emergency department, and alpha-adrenergic receptor blockers, such as tamsulosin, are commonly used to facilitate stone passage. OBJECTIVE: To determine if tamsulosin promotes the passage of urinary s …
IMPORTANCE: Urinary stone disease is a common presentation in the emergency department, and alpha-adrenergic receptor blockers, such as t
The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study.
Roehrborn CG, Siami P, Barkin J, Damião R, Major-Walker K, Nandy I, Morrill BB, Gagnier RP, Montorsi F; CombAT Study Group. Roehrborn CG, et al. Eur Urol. 2010 Jan;57(1):123-31. doi: 10.1016/j.eururo.2009.09.035. Epub 2009 Sep 19. Eur Urol. 2010. PMID: 19825505 Clinical Trial.
INTERVENTION: Oral daily tamsulosin, 0.4 mg; dutasteride, 0.5 mg; or a combination of both. MEASUREMENTS: The 4-yr primary end point was time to first AUR or BPH-related surgery. ...RESULTS AND LIMITATIONS: Combination therapy was significantly superior to tamsulosin
INTERVENTION: Oral daily tamsulosin, 0.4 mg; dutasteride, 0.5 mg; or a combination of both. MEASUREMENTS: The 4-yr primary end point …
A randomized, comparative, open-label study of efficacy and tolerability of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasia.
Manjunatha R, Pundarikaksha HP, Madhusudhana HR, Amarkumar J, Hanumantharaju BK. Manjunatha R, et al. Indian J Pharmacol. 2016 Mar-Apr;48(2):134-40. doi: 10.4103/0253-7613.178825. Indian J Pharmacol. 2016. PMID: 27127315 Free PMC article. Clinical Trial.
Alfuzosin, tamsulosin, and silodosin are comparable in efficacy in symptomatic management of BPH. The occurrence of QTc prolongation in three subjects with tamsulosin in the present study is an unexpected adverse event as there are no reports of QTc prolongation wit …
Alfuzosin, tamsulosin, and silodosin are comparable in efficacy in symptomatic management of BPH. The occurrence of QTc prolongation …
Anti-osteoporotic drugs affect the pathogenesis of gut microbiota and its metabolites: a clinical study.
Zhang RK, Yan K, Chen HF, Zhang Y, Li GJ, Chen XG, Ge LP, Cheng F, Chen ZN, Yao XM. Zhang RK, et al. Front Cell Infect Microbiol. 2023 Jul 4;13:1091083. doi: 10.3389/fcimb.2023.1091083. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37475958 Free PMC article. Clinical Trial.
The metabolites for which major changes were observed were capsazepine, Phe-Tyr, dichlorprop, D-pyroglutamic acid and tamsulosin. These metabolites may act through metabolic pathways, the citrate cycle (TCA cycle) and beta alanine metabolism. Combined analysis showed that …
The metabolites for which major changes were observed were capsazepine, Phe-Tyr, dichlorprop, D-pyroglutamic acid and tamsulosin. The …
Pumpkin seed oil (Cucurbita pepo) versus tamsulosin for benign prostatic hyperplasia symptom relief: a single-blind randomized clinical trial.
Zerafatjou N, Amirzargar M, Biglarkhani M, Shobeirian F, Zoghi G. Zerafatjou N, et al. BMC Urol. 2021 Oct 19;21(1):147. doi: 10.1186/s12894-021-00910-8. BMC Urol. 2021. PMID: 34666728 Free PMC article. Clinical Trial.
Patients were randomized into two groups. One group received 0.4 mg tamsulosin every night at bedtime and the other received 360 mg pumpkin seed oil twice a day. ...None of the patients in the pumpkin group experienced drug side effects, while dizziness (5.9%), headache (2 …
Patients were randomized into two groups. One group received 0.4 mg tamsulosin every night at bedtime and the other received 360 mg p …
Brachytherapy-related dysuria.
Merrick GS, Butler WM, Wallner KE, Allen Z, Galbreath RW, Lief JH. Merrick GS, et al. BJU Int. 2005 Mar;95(4):597-602. doi: 10.1111/j.1464-410X.2005.05346.x. BJU Int. 2005. PMID: 15705087 Clinical Trial.

RESULTS: The maximum incidence of dysuria was 85% at 1 month after brachytherapy, with subsequent resolution over time. The use of prophylactic tamsulosin resulted in a statistically lower dysuria severity score (difference of 2.7 vs 4.2, P < 0.005) at 1 month, with no

RESULTS: The maximum incidence of dysuria was 85% at 1 month after brachytherapy, with subsequent resolution over time. The use of prophylac …
A Comparison of Boron Supplement and Tamsulosin as Medical Expulsive Therapy for Urinary Stones After Extracorporeal Shock Wave Lithotripsy: a Randomized Controlled Clinical Trial.
Jalali S, Borumandnia N, Basiri A, Nagiee M, Amiri FB, Tavasoli S, Kheirolahkhani Y, Taheri M. Jalali S, et al. Biol Trace Elem Res. 2023 Nov;201(11):5126-5133. doi: 10.1007/s12011-023-03597-0. Epub 2023 Feb 21. Biol Trace Elem Res. 2023. PMID: 36808295 Clinical Trial.
We aimed to compare the effectiveness of boron supplement (due to its anti-inflammatory effect) and tamsulosin in the passage of stone fragments after ESWL. Eligible patients after ESWL were randomly assigned to two groups and were treated with boron supplement (10 mg/BD) …
We aimed to compare the effectiveness of boron supplement (due to its anti-inflammatory effect) and tamsulosin in the passage of ston …
Combination therapy with tamsulosin and traditional herbal medicine for lower urinary tract symptoms due to benign prostatic hyperplasia: A double-blinded, randomized, pilot clinical trial.
Lee CL, Shin HK, Lee JY, Kwon O, Seo CS, Kim AR, Seo BN, Yang SW, Song KH, Lim JS, Park JM, Na YG, Shin JH. Lee CL, et al. Int J Urol. 2022 Jun;29(6):503-509. doi: 10.1111/iju.14821. Epub 2022 Mar 16. Int J Urol. 2022. PMID: 35297106 Free PMC article. Clinical Trial.
OBJECTIVES: To evaluate the efficacy and safety of tamsulosin and Hachimijiogan or Ryutanshakanto in patients with lower urinary tract symptoms due to benign prostatic hyperplasia. ...Only the pain sub-score of the National Institutes of Health-Chronic Prostatitis Symptom …
OBJECTIVES: To evaluate the efficacy and safety of tamsulosin and Hachimijiogan or Ryutanshakanto in patients with lower urinary trac …
Comparative study between Tamsulosin, Silodosin and Tadalafil as a medical expulsive therapy for lower ureteral stones.
Abdelaal MA, El-Dydamony EM. Abdelaal MA, et al. Arch Ital Urol Androl. 2023 Feb 22;95(1):10849. doi: 10.4081/aiua.2023.10849. Arch Ital Urol Androl. 2023. PMID: 36924384 Free article. Clinical Trial.
OBJECTIVE: To compare the efficacy of Tamsulosin, Silodosin and Tadalafil as a medical expulsive therapy for treatment of distal ureteral calculi. ...Patients were randomly divided into three groups. Patients in group A received Tamsulosin 0.4mg, in group B received …
OBJECTIVE: To compare the efficacy of Tamsulosin, Silodosin and Tadalafil as a medical expulsive therapy for treatment of distal uret …
Distal Ureteric Stones and Tamsulosin: A Double-Blind, Placebo-Controlled, Randomized, Multicenter Trial.
Furyk JS, Chu K, Banks C, Greenslade J, Keijzers G, Thom O, Torpie T, Dux C, Narula R. Furyk JS, et al. Ann Emerg Med. 2016 Jan;67(1):86-95.e2. doi: 10.1016/j.annemergmed.2015.06.001. Epub 2015 Jul 17. Ann Emerg Med. 2016. PMID: 26194935 Free article. Clinical Trial.
STUDY OBJECTIVE: We assess the efficacy and safety of tamsulosin compared with placebo as medical expulsive therapy in patients with distal ureteric stones less than or equal to 10 mm in diameter. ...In the subgroup with large stones (5 to 10 mm), tamsulosin did inc …
STUDY OBJECTIVE: We assess the efficacy and safety of tamsulosin compared with placebo as medical expulsive therapy in patients with …
528 results